(Alliance News) - Stocks closed mostly higher on Thursday, although the pound remained under pressure, as a degree of calmness returned to bond markets after recent volatility. Miners led the way in ...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ...

Marula, a London-based mining company focused on South Africa, said the new license will cover 7,219 hectares of land. The area borders Marula's Blesberg lithium and tantalum prospect and the Northern ...

(Alliance News) - Customers of Lloyds Banking Group PLC, Halifax and Bank of Scotland will be able to use the branches of any brand for in-person banking as the group continues to shake up its branch ...

(Alliance News) - Online fast-fashion retailer Shein is aiming to list in London in the first half of the year, Reuters reported on Thursday, assuming it gains regulatory approvals for the initial ...

(Alliance News) - De La Rue PLC on Thursday said it is "considering its options" after receiving a bid proposal worth 125 pence per share. The offer from Disruptive Capital GP Ltd and Pension ...

(Alliance News) - Households may face a further income squeeze, with the potential for upward pressure on mortgage rates and some prices perhaps becoming more expensive, experts have said.

In early UK corporate news, Christmas trading updates from high street names rolled in. Tesco maintained annual guidance, B&M narrowed its profit outlook and M&S reported decent growth in its Food arm ...

(Alliance News) - London's FTSE 100 is set to open higher on Thursday, shaking off tepid China data and concerns over the US interest rate outlook. IG says futures indicate the FTSE 100 to open 17.0 ...

(Alliance News) - Ferrexpo PLC on Thursday said production surged by 25% during the final quarter of 2024, bringing its annual production totals nearly 50% higher.

Scancell reported "good safety and tolerability" of Modi-1. The early results will only be verified after a total of up to 21 patients have been vaccinated, though Scancell is confident about moving ...

"It's fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted treatment option for certain people with locally advanced or secondary breast cancer who ...